Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea P Myers

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 4, 2013
New strategies in endometrial cancer: targeting the PI3K/mTOR pathway--the devil is in the detailsAndrea P Myers
Nutrition (Burbank, Los Angeles County, Calif.)|August 29, 2012
Sugar free, cancer free?Andrea P Myers, Lewis C Cantley
Science Translational Medicine|September 10, 2010
Targeting a common collaborator in cancer developmentAndrea P Myers, Lewis C Cantley
Cancer Discovery|November 23, 2013
What a tangled web we weave: emerging resistance mechanisms to inhibition of the phosphoinositide 3-kinase pathwaySamuel J Klempner, Andrea P Myers, Lewis C Cantley
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 12, 2009
Getting knit-PI3Ky: PIK3CA mutation status to direct multimodality therapy?Andrea P Myers, Jeffrey A Meyerhardt, Lewis C Cantley
Science Translational Medicine|January 11, 2013
Repurposing the Pap smear: one step closer to gynecologic cancer screeningShannon N Westin, Gordon B Mills, Andrea P Myers
Expert Opinion on Pharmacotherapy|August 14, 2013
Clinical investigation of receptor and non-receptor tyrosine kinase inhibitors for the treatment of epithelial ovarian cancerSamuel J Klempner, Andrea P Myers, Gordon B Mills, et al.
Malaria Journal|February 17, 2009
Micro-geographic risk factors for malarial infectionWard P Myers, Andrea P Myers, Janet Cox-Singh, et al.
Gynecologic Oncology|March 27, 2016
Tumor mutational analysis of GOG248, a phase II study of temsirolimus or temsirolimus and alternating megestrol acetate and tamoxifen for advanced endometrial cancer (EC): An NRG Oncology/Gynecologic Oncology Group studyAndrea P Myers, Virginia L Filiaci, Yuping Zhang, et al.
Cancer Research|December 11, 2013
A genetic mouse model of invasive endometrial cancer driven by concurrent loss of Pten and Lkb1 Is highly responsive to mTOR inhibitionHailing Cheng, Pixu Liu, Fan Zhang, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 4, 2013
New strategies in endometrial cancer: targeting the PI3K/mTOR pathway--the devil is in the detailsAndrea P Myers
Nutrition (Burbank, Los Angeles County, Calif.)|August 29, 2012
Sugar free, cancer free?Andrea P Myers, Lewis C Cantley
Science Translational Medicine|September 10, 2010
Targeting a common collaborator in cancer developmentAndrea P Myers, Lewis C Cantley
Cancer Discovery|November 23, 2013
What a tangled web we weave: emerging resistance mechanisms to inhibition of the phosphoinositide 3-kinase pathwaySamuel J Klempner, Andrea P Myers, Lewis C Cantley
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 12, 2009
Getting knit-PI3Ky: PIK3CA mutation status to direct multimodality therapy?Andrea P Myers, Jeffrey A Meyerhardt, Lewis C Cantley
Science Translational Medicine|January 11, 2013
Repurposing the Pap smear: one step closer to gynecologic cancer screeningShannon N Westin, Gordon B Mills, Andrea P Myers
Expert Opinion on Pharmacotherapy|August 14, 2013
Clinical investigation of receptor and non-receptor tyrosine kinase inhibitors for the treatment of epithelial ovarian cancerSamuel J Klempner, Andrea P Myers, Gordon B Mills, et al.
Malaria Journal|February 17, 2009
Micro-geographic risk factors for malarial infectionWard P Myers, Andrea P Myers, Janet Cox-Singh, et al.
Gynecologic Oncology|March 27, 2016
Tumor mutational analysis of GOG248, a phase II study of temsirolimus or temsirolimus and alternating megestrol acetate and tamoxifen for advanced endometrial cancer (EC): An NRG Oncology/Gynecologic Oncology Group studyAndrea P Myers, Virginia L Filiaci, Yuping Zhang, et al.
Cancer Research|December 11, 2013
A genetic mouse model of invasive endometrial cancer driven by concurrent loss of Pten and Lkb1 Is highly responsive to mTOR inhibitionHailing Cheng, Pixu Liu, Fan Zhang, et al.
Pageof 2